Back to Journals » Biologics: Targets and Therapy » Volume 6

Review

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors

         
Total article views   Abstract views HTML views PDF downloads Totals
13,298 Dovepress* 9,042 577+ 2,374 9,619
PubMed Central* 3 3,676 1,140 3,679
Totals 9,045 4,253 3,514 13,298
*Since 25 September 2012
+Since July 2016

View citations on PubMed Central and Google Scholar